Jingpei Long

511 total citations
16 papers, 386 citations indexed

About

Jingpei Long is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jingpei Long has authored 16 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Jingpei Long's work include Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Jingpei Long is often cited by papers focused on Circular RNAs in diseases (5 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Jingpei Long collaborates with scholars based in China, United States and Belgium. Jingpei Long's co-authors include Lifeng Dong, Fangfang Chen, Zhiwei Ji, Kai Jiang, Zhaoyang Wang, Guanmin Meng, Xiaoli Li, Qianhua Cao, Qiang Fu and Huixin Liu and has published in prestigious journals such as The Journal of Experimental Medicine, BioMed Research International and Journal of Cellular Biochemistry.

In The Last Decade

Jingpei Long

15 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jingpei Long China	10	290	213	74	40	34	16	386
Surong Zhao China	11	247 0.9×	198 0.9×	80 1.1×	28 0.7×	30 0.9×	25	364
Chaoquan Hu China	10	284 1.0×	183 0.9×	111 1.5×	31 0.8×	38 1.1×	11	409
Joseph G. Kern United States	6	316 1.1×	247 1.2×	61 0.8×	37 0.9×	54 1.6×	10	473
Wenbin Zhang China	10	348 1.2×	138 0.6×	65 0.9×	42 1.1×	35 1.0×	15	481
Peipei Nie China	8	277 1.0×	163 0.8×	71 1.0×	23 0.6×	35 1.0×	8	400
Changjiang Lei China	13	266 0.9×	196 0.9×	52 0.7×	52 1.3×	20 0.6×	26	384
Chee Wai Fhu Singapore	8	300 1.0×	228 1.1×	95 1.3×	35 0.9×	60 1.8×	8	478
Xinming Chi China	11	246 0.8×	126 0.6×	58 0.8×	22 0.6×	53 1.6×	19	351
Shi Li China	10	246 0.8×	155 0.7×	43 0.6×	61 1.5×	35 1.0×	19	344
Jinbao Guo China	14	415 1.4×	152 0.7×	115 1.6×	46 1.1×	71 2.1×	19	535

Countries citing papers authored by Jingpei Long

Since Specialization

Citations

This map shows the geographic impact of Jingpei Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingpei Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingpei Long more than expected).

Fields of papers citing papers by Jingpei Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingpei Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingpei Long. The network helps show where Jingpei Long may publish in the future.

Co-authorship network of co-authors of Jingpei Long

This figure shows the co-authorship network connecting the top 25 collaborators of Jingpei Long. A scholar is included among the top collaborators of Jingpei Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingpei Long. Jingpei Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Ye, Xiaohang, et al.. (2025). Risk Factors for Totally Implantable Access Ports Associated Complications in Breast Cancer Patients. Cancer Control. 32. 2935754455–2935754455.

Wang, Zhen, Jingpei Long, Lu Cheng, et al.. (2022). Ribonucleotide reductase M2 subunit silencing suppresses tumorigenesis in pancreatic cancer via inactivation of PI3K/AKT/mTOR pathway. Pancreatology. 22(3). 401–413. 11 indexed citations

Wang, Yike, Lifeng Dong, Fangping Wan, et al.. (2021). MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH. Cell Death and Disease. 12(10). 861–861. 17 indexed citations

Chen, Deqin, Yike Wang, Jingpei Long, et al.. (2021). Downregulation of long non‑coding RNA MR4435‑2HG suppresses breast cancer progression via the Wnt/β‑catenin signaling pathway. Oncology Letters. 21(5). 373–373. 19 indexed citations

Dong, Lifeng, et al.. (2020). MiR-34b-5p inhibits cell proliferation, migration and invasion through targeting ARHGAP1 in breast cancer.. PubMed. 12(1). 269–280. 21 indexed citations

Dong, Lifeng, et al.. (2019). LINC00461 promotes cell migration and invasion in breast cancer through miR‐30a‐5p/integrin β3 axis. Journal of Cellular Biochemistry. 120(4). 4851–4862. 36 indexed citations

Long, Jingpei, et al.. (2018). miR‑146a‑5p targets interleukin‑1 receptor‑associated kinase�1 to inhibit the growth, migration, and invasion of breast cancer cells. Oncology Letters. 17(2). 1573–1580. 29 indexed citations

Wu, Xuebiao, Xiaoli Li, Qiang Fu, et al.. (2017). AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program. The Journal of Experimental Medicine. 214(4). 1065–1079. 108 indexed citations

Dong, Lifeng, et al.. (2017). Role of number of sentinel nodes in predicting non-sentinel node metastasis in breast cancer. Journal of International Medical Research. 46(2). 828–835. 3 indexed citations

10.

Dong, Lifeng, Shuying Xu, Jingpei Long, Fangping Wan, & Yiding Chen. (2017). RNA-Sequence Analysis Reveals Differentially Expressed Genes (DEGs) in Patients Exhibiting Different Risks of Tumor Metastasis. Medical Science Monitor. 23. 2842–2849. 8 indexed citations

11.

Long, Jingpei. (2016). Targeting metabolism in breast cancer: How far we can go?. World Journal of Clinical Oncology. 7(1). 122–122. 51 indexed citations

12.

Zhang, Feng, Yuehong Chen, Jingpei Long, et al.. (2015). Dietary Fatty Acids Affect Lipid Metabolism and Estrogen Receptor Expression in N-Methyl-N-Nitrosourea-Induced Rat Mammary Cancer Model. Clinical Laboratory. 61(03+04/2015). 389–95. 4 indexed citations

13.

Long, Jingpei, Zhiwei Ji, Kai Jiang, Zhaoyang Wang, & Guanmin Meng. (2015). miR-193b Modulates Resistance to Doxorubicin in Human Breast Cancer Cells by Downregulating MCL-1. BioMed Research International. 2015. 1–9. 44 indexed citations

14.

Zhang, Feng, et al.. (2015). Effect of n-3 and n-6 Polyunsaturated Fatty Acids on Lipid Metabolic Genes and Estrogen Receptor Expression in MCF-7 Breast Cancer Cells. Clinical Laboratory. 61(03+04/2015). 397–403. 3 indexed citations

15.

Wan, Fangping, et al.. (2014). A Systemic Analysis on Pemetrexed in Treating Patients with Breast Cancer. Asian Pacific Journal of Cancer Prevention. 15(11). 4567–4570. 4 indexed citations

16.

Zhou, Jun, Huiyong Hu, Jingpei Long, et al.. (2013). Vitexin 6, a novel lignan, induces autophagy and apoptosis by activating the Jun N-terminal kinase pathway. Anti-Cancer Drugs. 24(9). 928–936. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact